Novavax debuts new Covid vaccination campaign as millions of US doses shipnews2023-10-10T18:13:49+00:00October 10th, 2023|Endpoints News|
EuroAPI stock craters after 2023 revenue forecast slashednews2023-10-10T17:25:22+00:00October 10th, 2023|Endpoints News|
MarketingRx roundup: Pharma brands get creative on Instagram; J&J reups health equity challengenews2023-10-10T16:03:22+00:00October 10th, 2023|Endpoints News|
Bessemer report details state of health tech in 2023, from funding cycles to how public markets have farednews2023-10-10T16:00:08+00:00October 10th, 2023|Endpoints News|
Verily lays out ‘Chapter 3’, streamlining its business under a new CEOnews2023-10-10T15:55:41+00:00October 10th, 2023|Endpoints News|
CEPI puts $25M into Rift Valley fever vaccine; Gates invests in AI for scientists in Africa in equity bidnews2023-10-10T15:16:09+00:00October 10th, 2023|Endpoints News|
How CVS and Walgreens are becoming pharma’s new big advertising strategynews2023-10-10T15:10:15+00:00October 10th, 2023|Endpoints News|
Bayer takes next step in cell therapy, opening new $250M facility in Berkeleynews2023-10-10T14:54:50+00:00October 10th, 2023|Endpoints News|
Merck says Keytruda improves survival before and after lung cancer surgery, awaits FDA decision next weeknews2023-10-10T14:44:52+00:00October 10th, 2023|Endpoints News|
Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startupnews2023-10-10T13:49:41+00:00October 10th, 2023|Endpoints News|
